AUG 22, 2013 09:00 AM PDT

Next-Gen Sequencing: Driving the Transition from Genetics to Genomics

222 44 3863

  • CEO, CSO and Co-Founder, AllSeq, Inc.
      Dr. Shawn C. Baker is the Chief Science Officer and co-founder of AllSeq. Having received his Ph.D. at the University of California - Davis, he started his career as a Research Scientist at Illumina when it was a 15-person startup. After spending several years at the bench developing gene expression array products, he transitioned to Product Marketing where he led a team in charge of Illuminas Expression and Regulation sequencing portfolio. In 2013 Dr. Baker co-founded AllSeq, establishing the only true sequencing marketplace, matching researchers with service providers based on their needs.
      <br />

    The rapid advancements in next generation sequencing have served the research market very well, delivering more and more sequence for less and less money. While these advancements are still being made, the market is now looking toward serving a new customer - the clinician. For both technology platforms and informatics solutions, the emphasis is now on speed, quality and ease of use. An understanding of this market and where it is headed will help in predicting the broad implications for the future of medicine.

    Show Resources
    Loading Comments...